Samantha G Farris1, Nicholas P Allan2, Patricia C Morales3, Norman B Schmidt2, Michael J Zvolensky4. 1. University of Houston, Department of Psychology, 126 Fred J. Heyne Building, Suite 104, Houston, TX 77204, USA. Electronic address: sgfarris@uh.edu. 2. Florida State University, Department of Psychology, 1107 West Call Street, Tallahassee, FL 32306, USA. 3. The University of Texas MD Anderson Cancer Center, Department of Behavioral Science, 1155 Pressler Street, Houston, TX 77030, USA. 4. University of Houston, Department of Psychology, 126 Fred J. Heyne Building, Suite 104, Houston, TX 77204, USA; The University of Texas MD Anderson Cancer Center, Department of Behavioral Science, 1155 Pressler Street, Houston, TX 77030, USA.
Abstract
INTRODUCTION: There is limited work that has examined the effect of quitting smoking on anxious arousal, an underlying dimension of anxiety symptoms and psychopathology. METHOD:Smokers (n=185, 54.1% female) enrolled in a smoking cessation treatment trial were monitored post-cessation in terms of abstinence status (biochemically verified; at Weeks 1, 2, and Month 1 post-quit) and severity of panic-relevant symptoms (self-reported; at Month 1 and 3 post-quit). Structural equation models were conducted, adjusting for participant sex, age, treatment condition, and pre-cessation nicotine dependence, presence of depressive/anxiety disorders, anxious arousal, and anxiety sensitivity. RESULTS: After adjusting for covariates, participants who remained abstinent for one month (n=80; 43.2%) relative to those who did not (n=105; 56.8%) demonstrated significant reductions in anxious arousal at Month 1 (β=-.26, p=.04) and Month 3 post-quit (β=-.36, p=.006); abstinence status had a non-significant effect on anxious arousal severity at Month 3 after controlling for Month 1 anxious arousal (β=-.18, p=.09). DISCUSSION: Findings align with theoretical models of smoking-anxiety interplay and suggest that smoking cessation can result in reductions in anxious arousal.
RCT Entities:
INTRODUCTION: There is limited work that has examined the effect of quitting smoking on anxious arousal, an underlying dimension of anxiety symptoms and psychopathology. METHOD: Smokers (n=185, 54.1% female) enrolled in a smoking cessation treatment trial were monitored post-cessation in terms of abstinence status (biochemically verified; at Weeks 1, 2, and Month 1 post-quit) and severity of panic-relevant symptoms (self-reported; at Month 1 and 3 post-quit). Structural equation models were conducted, adjusting for participant sex, age, treatment condition, and pre-cessation nicotine dependence, presence of depressive/anxiety disorders, anxious arousal, and anxiety sensitivity. RESULTS: After adjusting for covariates, participants who remained abstinent for one month (n=80; 43.2%) relative to those who did not (n=105; 56.8%) demonstrated significant reductions in anxious arousal at Month 1 (β=-.26, p=.04) and Month 3 post-quit (β=-.36, p=.006); abstinence status had a non-significant effect on anxious arousal severity at Month 3 after controlling for Month 1 anxious arousal (β=-.18, p=.09). DISCUSSION: Findings align with theoretical models of smoking-anxiety interplay and suggest that smoking cessation can result in reductions in anxious arousal.
Authors: Michael J Zvolensky; Sherry H Stewart; Anka A Vujanovic; Dubravka Gavric; Dan Steeves Journal: Nicotine Tob Res Date: 2009-02-23 Impact factor: 4.244
Authors: Douglas Ziedonis; Brian Hitsman; Jean C Beckham; Michael Zvolensky; Lawrence E Adler; Janet Audrain-McGovern; Naomi Breslau; Richard A Brown; Tony P George; Jill Williams; Patrick S Calhoun; William T Riley Journal: Nicotine Tob Res Date: 2008-12 Impact factor: 4.244
Authors: Christopher W Kahler; Anthony Surace; Rebecca E F Gordon; Patricia A Cioe; Nichea S Spillane; Acacia Parks; Beth C Bock; Richard A Brown Journal: Contemp Clin Trials Date: 2018-06-21 Impact factor: 2.226